Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell

NCT04520035 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

PFS

Interventions

DRUG: camrelizumab
DRUG: Paclitaxel
DRUG: Neoadjuvant Chemotherapy

Sponsor

Fudan University